PCM
EW icon

Prelude Capital Management’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,861
Closed -$218K 1261
2023
Q4
$218K Buy
+2,861
New +$218K 0.01% 783
2023
Q3
Sell
-5,715
Closed -$539K 1059
2023
Q2
$539K Sell
5,715
-3,078
-35% -$290K 0.04% 369
2023
Q1
$727K Buy
8,793
+4,003
+84% +$331K 0.04% 331
2022
Q4
$357K Buy
4,790
+1,257
+36% +$93.8K 0.02% 622
2022
Q3
$292K Buy
+3,533
New +$292K 0.01% 859
2021
Q4
Sell
-3,443
Closed -$390K 1680
2021
Q3
$390K Buy
+3,443
New +$390K 0.01% 762
2020
Q2
Sell
-649
Closed -$122K 1424
2020
Q1
$122K Sell
649
-4,831
-88% -$908K 0.01% 324
2019
Q4
$1.28M Buy
5,480
+5,221
+2,016% +$1.22M 0.05% 141
2019
Q3
$57K Buy
+259
New +$57K ﹤0.01% 724
2019
Q2
Sell
-4,253
Closed -$814K 1373
2019
Q1
$814K Buy
+4,253
New +$814K 0.05% 194
2018
Q4
Sell
-560
Closed -$97K 1488
2018
Q3
$97K Sell
560
-8,953
-94% -$1.55M 0.01% 680
2018
Q2
$1.39M Buy
9,513
+828
+10% +$121K 0.09% 181
2018
Q1
$1.21M Buy
8,685
+743
+9% +$104K 0.09% 192
2017
Q4
$895K Buy
+7,942
New +$895K 0.07% 239
2017
Q3
Sell
-65
Closed -$8K 1569
2017
Q2
$8K Sell
65
-200
-75% -$24.6K ﹤0.01% 1302
2017
Q1
$25K Sell
265
-3,791
-93% -$358K ﹤0.01% 1175
2016
Q4
$380K Sell
4,056
-4,965
-55% -$465K 0.05% 341
2016
Q3
$1.09M Buy
9,021
+2,540
+39% +$306K 0.11% 182
2016
Q2
$646K Buy
6,481
+2,659
+70% +$265K 0.09% 225
2016
Q1
$337K Buy
3,822
+2,582
+208% +$228K 0.05% 329
2015
Q4
$98K Buy
1,240
+540
+77% +$42.7K 0.02% 765
2015
Q3
$100K Buy
700
+200
+40% +$28.6K 0.01% 772
2015
Q2
$71K Sell
500
-1,132
-69% -$161K 0.01% 950
2015
Q1
$232K Sell
1,632
-1,842
-53% -$262K 0.03% 570
2014
Q4
$443K Sell
3,474
-13,380
-79% -$1.71M 0.06% 316
2014
Q3
$1.72M Buy
16,854
+15,901
+1,669% +$1.62M 0.24% 73
2014
Q2
$82K Buy
+953
New +$82K 0.01% 1053
2013
Q4
Sell
-2,750
Closed -$191K 1584
2013
Q3
$191K Buy
2,750
+1,950
+244% +$135K 0.03% 485
2013
Q2
$54K Buy
+800
New +$54K 0.01% 725